Berberine Inhibits Growth of the Breast Cancer Cell Lines MCF-7 and MDA-MB-231

Abstract

The effects of berberine on the behavior of breast tumors have not yet been established. To determine whether this compound is useful in the treatment of breast cancer, we analyzed the impact of berberine on the human breast cancer cell lines MCF-7 and MDA-MB-231 cells. Berberine was added to proliferating MCF-7 and MDA-MB-231 cells in culture. Following treatment, changes in cell growth characteristics such as proliferation, cell cycle duration, and the degree of apoptosis were assayed. Following berberine treatment, a time-dependent reduction in proliferation was observed in both cell lines at differing concentrations: 20 μM for MCF-7 and 10 μM for MDA-MB-231 cells. Annexin V staining showed an increase in apoptosis in both cell lines of 31 % in MCF-7and 12 % in MDA-MB-231 cells compared to their respective controls. In addition, 12 % of the MCF-7 cells were arrested at G0/G1, compared to 62 % of control cells. These results demonstrate that treatment with berberine inhibits growth in both MDA-MB-231 and MCF-7 cells. In addition, they show that this partly occurs through the induction of apoptosis in MDA-MB-231 cells, and through both cell cycle arrest and induction of apoptosis in MCF-7 cells. Thus, berberine may be a novel therapeutic drug for breast cancer.

Key words

Berberine - breast cancer - MCF-7 - MDA-MB-231 - apoptosis

References

• 1 Jantova S, Cipak L, Cernakova M, Kost'alova D. Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells.  J Pharm Pharmacol. 2003;  55 1143-9
• 2 Lee S, Lim H J, Park H Y, Lee K S, Park J H, Jang Y. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model.  Atherosclerosis. 2006;  186 29-37
• 3 Abidi P, Zhou Y, Jiang J D, Liu J. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine.  Arterioscler Thromb Vasc Biol. 2005;  25 2170-6
• 4 Issat T, Jakobisiak M, Golab J. Berberine, a natural cholesterol reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway.  Oncol Rep. 2006;  16 1273-6
• 5 Kuo C L, Chi C W, Liu T Y. Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells.  In Vivo. 2005;  19 247-52
• 6 Leng S H, Lu F E, Xu L J. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion.  Acta Pharmacol Sin. 2004;  25 496-502
• 7 Jantova S, Letasiova S, Brezova V, Cipak L, Labaj J. Photochemical and phototoxic activity of berberine on murine fibroblast NIH-3T3 and Ehrlich ascites carcinoma cells.  J Photochem Photobiol B. 2006;  85 163-76
• 8 Inoue K, Kulsum U, Chowdhury S A, Fujisawa S, Ishihara M, Yokoe I. et al . Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines.  Anticancer Res. 2005;  25 4053-9
• 9 Mantena S K, Sharma S D, Katiyar S K. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP.  Carcinogenesis. 2006;  27 2018-27
• 10 Lin C C, Kao S T, Chen G W, Ho H C, Chung J G. Apoptosis of human leukemia HL 60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3.  Anticancer Res. 2006;  26 227-42
• 11 Letasiova S, Jantova S, Miko M, Ovadekova R, Horvathova M. Effect of berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich ascites carcinoma cells.  J Pharm Pharmacol. 2006;  58 263-70
• 12 Peng P L, Hsieh Y S, Wang C J, Hsu J L, Chou F P. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase plasminogen activator and matrix metalloproteinase-2.  Toxicol Appl Pharmacol . 2006;  214 8-15
• 13 Orfila L, Rodriguez M, Colman T, Hasegawa M, Merentes E, Arvelo F. Structural modification of berberine alkaloids in relation to cytotoxic activity in vitro. .  J Ethnopharmacol. 2000;  71 449-56
• 14 Lin J G, Chung J G, Wu L T, Chen G W, Chang H L, Wang T F. Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells.  Am J Chin Med. 1999;  27 265-75
• 15 Kang M R, Chung I K. Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine.  Mol Pharmacol. 2002;  61 879-84
• 16 Kim S A, Kwon Y, Kim J H, Muller M T, Chung I K. Induction of topoisomerase II mediated DNA cleavage by a protoberberine alkaloid, berberrubine.  Biochemistry. 1998;  37 16 316-24
• 17 Wu S N, Yu H S, Jan C R, Li H F, Yu C L. Inhibitory effects of berberine on voltage- and calcium-activated potassium currents in human myeloma cells.  Life Sci. 1998;  62 2283-94
• 18 Sheridan C, Kishimoto H, Fuchs R K, Mehrotra S, Bhat-Nakshatri P, Turner C H. et al . CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis.  Breast Cancer Res. 2006;  8 R59
• 19 Lin C C, Lin S Y, Chung J G, Lin J P, Chen G W, Kao S T. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle.  Anticancer Res. 2006;  26 1097-104